Documentos de Schijman A.G. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Área temáticas: "Enfermedades"

Subtipo de publicación

Publisher

Acta Tropica(1)

Infection and Immunity(1)

Journal of Molecular Diagnostics(1)

PLoS Neglected Tropical Diseases(1)

Área temáticas

Microorganismos, hongos y algas(2)

Anatomía humana, citología, histología(1)

Fisiología humana(1)

Medicina forense; incidencia de enfermedades(1)

Medicina y salud(1)

Área de conocimiento

Microbiología(2)

Biología molecular(1)

Inmunología(1)

Parasitología(1)

Año de Publicación

Origen

Palabras Claves

Chagas disease(1)

Chemotherapy response(1)

Chronic infection(1)

Analytical validation of quantitative real-time PCR methods for quantification of trypanosoma cruzi DNA in blood samples from chagas disease patients

Abstract: An international study was performed by 26 experienced PCR laboratories from 14 countries to assess

Palabras claves:

Alberti A., Alvarez-Martínez M., Aznar C., Bisio M., Crisante G.E., Cruz-Robles D., Cura C.I., Da Câmara A.C.J., Da Cruz Moreira O., de Noya B.A., De Paoli de Carvalho Britto C.F., Diosque P., Espinoza B., Flores-Chávez M.D., Greif G., Guhl F., Jaime Alfredo Costales, Juiz N., Marcet P.L., Marcos Da Matta Guedes P., Maria Da Cunha Galvão L., Martínez N.E., Muñoz-Calderón A., Padilla C., Parrado R., Pavia P., Peneau J., Pérez-Morales D., Puerta C., Ramírez J.C., Ramírez J.D., Riarte A., Ribeiro I., Sánchez Z., Santalla J., Schijman A.G., Silva E.L., Sosa-Estani S., Valencia E., Velázquez E., Villarroel R., Villarroel S., Yadón Z.E., Zulantay I.

Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi

Abstract: Trypanosoma cruzi infection of host cells is a complex process in which many proteins participate bu

Palabras claves:

Alejandra Beatriz Barrio, Basombŕo M.A., Duffy T., Rubén Marino Cardozo, Schijman A.G., Zago M.P.

Serological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.

Abstract: Chagas disease, caused by the protozoan Trypanosoma cruzi, affects more than 6 million people worldw

Palabras claves:

3973, antigens, Chagas disease, Chemotherapy response, Chronic infection, F29, hsp70, InfYnity multiplexed ELISA, KMP11, PFR2, TRYPANOSOMA CRUZI

Abril M., Alonso-Padillaid J., Benítez C., Casellas A., Chatelain E., de Noya B.A., Esteva M., Gascón J., Gómez I., Granjon E., Guhl F., Hasslochermoreno A.M., Jorge T.A., Longhi S.A., López M.C., Luquetti A.O., Mario J. Grijalva, Méndez S., Noya O., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Sanz S., Schijman A.G., Sosa-Estani S., Thomas M.C., Torrico F., Viotti R., Zrein M.

Target product profile for a test for the early assessment of treatment efficacy in chagas disease patients: An expert consensus

Palabras claves:

Abril M., Almeida I.C., Alonso-Padillaid J., Angheben A., Carmen Thomas M., Chatelain E., de Noya B.A., Esteva M., Gascón J., Guhl F., Hasslochermoreno A.M., Jorge T.A., López M.C., Luquetti A.O., Mario J. Grijalva, Noya O., Picado A., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Schijman A.G., Sosa-Estani S., Torrico F., Zreinid M.